The level of melatonin and serotonin neurohormones in blood serum in patients with non-alcoholic fatty liver disease and kidney lesions infected with COVID-19 virus
Keywords:non-alcoholic fatty liver disease, type 2 diabetes mellitus, kidney damage, СOVID-19, melatonin, serotonin
Background. Research aimed at determining the possible mechanisms of progression in the damage to various organs and systems against the background of COVID-19 infection is an urgent, not thoroughly studied issue in contemporary clinical medicine. The purpose was to determine the peculiarities of changes in serum melatonin (МТ) and serotonin (ST) neurohormone levels in patients with non-alcoholic fatty liver disease (NAFLD) and kidney damage infected with the COVID-19 virus. Materials and methods. 84 patients with NAFLD (steatohepatitis) combined with increased body mass index were examined. NAFLD patients were divided into two groups depending on the presence or absence of type 2 diabetes mellitus (DM), and namely: Group 1 included 34 NAFLD and insulin resistance (IR) patients; Group 2 comprised 38 patients with NAFLD and type 2 DM. All examined patients were tested for MT and ST levels in blood serum. Results. There was a significant decrease in serum MT level in both examined groups — by 2.2 and 3.2 times respectively in group 1 and 2 patients at the time of admission to the hospital. The same trend was identified in the indicators of serum MT level in both groups of patients on day 1 of inpatient treatment (IT) — and namely, its decrease by 1.5 and 2.3 times. Revealed a correlation between the progression of liver damage and the decrease of MT and ST levels in blood serum, which is probably a consequence of its toxic damage against the background of the conducted treatment of patients infected with COVID-19. The decreased serum neurohormone levels also correlate with the insulin level and IR index. There is also a strong correlation between renal damage occurring at the IT stage in NAFLD patients and impaired carbohydrate metabolism during COVID-19 infection and decreased levels of MT and ST in the blood, according to glomerular filtration rate MDRD MDRD (r = 0,88; р < 0,01 and r = 0,94; р < 0,01 accordance). Conclusions. COVID-19 infection and its treatment in NAFLD patients with impaired carbohydrate metabolism lead to impaired renal functional status. In patients with NAFLD and carbohydrate metabolism disorders, a decrease in serum levels of the neurohormones MT and ST was found, which progressively decreased against the background of COVID-19 infection and kidney damage in these patients.
Ziaee A, Azarkar G, Ziaee M. Role of fatty liver in coronavirus disease 2019 patients' disease severity and hospitalization length: a case-control study. Eur J Med Res. 2021 Sep 26;26(1):115. doi: 10.1186/s40001-021-00590-y.
Popov SS, Pashkov AN, Esaulenko IE, Popova TN, Agarkov AA, Kuptsova GN. Antiapoptotic effect of melatonin in nonalcoholic steatohepatitis developing in patients with type 2 diabetes mellitus. Clinical endocrinology. 2018;63(3):162-168. doi: 10.14341/probl2017633162-168.
Zaichenko AV, Gorchakova NA. Serotonin: from neuromediator to drug. Bulletin of problems in biology and medicine. 2017;(137):49-56.
Mamchur VI, Nosivec DS, Khomyak EV. Melatonin as a secondary therapy for COVID-19. Family medicine. 2020;(89):13-19.
European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016 Jun;64(6):1388-402. doi: 10.1016/j.jhep.2015.11.004.
Ministry of Health of Ukraine. Order 1118 dated Dec 21, 2021. Type 2 Diabetes Mellitus: Unified clinical protocol for primary and secondary (specialized) medical care. Kyiv; 2012. 118p. (in Ukrainian).
Classification of diseases of the urinary system. Ukrainian Journal of Nephrology and Dialysis. 2018;(57):3-23. (in Ukranian).
Karstila K, Harmoinen AP, Lehtimäki TJ, Korpela MM, Mustonen JT, Saha HH. Measurement of the kidney function in patients with rheumatoid arthritis: plasma cystatin C versus 51Cr-EDTA clearance. Nephron Clin Pract. 2008;108(4):c284-90. doi: 10.1159/000127362.
Kolianyk ІО, Gerush ІV. Melatonin effect on the liver antioxidant system of rats with experimental nephropathy. Bulletin of Medical and Biological Research. 2020:(4):37-41. doi: 10.11603/bmbr.2706-6290.2020.4.11802.
Kryvchanska MI, Ryznychuk MO, Pishak VP. Morphological and functional changes in kidneys caused by propranolol: effects of melatonin. Morphologia. 2016;3(10):197-198. doi: 10.26641/1997-9665.2016.3.196-198.
Kondratiuk VE, Petrova AS, Karpenko OV. Characterization of melatonin-forming function of pineal gland in patients with end-stage chronic kidney disease. Clinical endocrinology and endocrine surgery. 2019(4):94-102. doi: 10.30978/CEES-2019-4-94.
Lychkova AE, Hoschenko YuA, Osipov PG, Fentisov VV. The effect of serotonin on structural state of kidneys (Literature review and own data). Scientific papers. Naucnye vedomosti Belgorodskogo gosudarstvennogo universiteta: Medicina, farmacia. 2016;(233):22-26.
How to Cite
This work is licensed under a Creative Commons Attribution 4.0 International License.